Werewolf Therapeutics, Inc.Werewolf Therapeutics, Inc.Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

No trades
See on Supercharts

HOWL fundamentals

Werewolf Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of HOWL for the last quarter is 1.50 M USD, and it's 74.55% lower compared to the previous quarter. The net income of Q4 23 is -12.00 M USD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth